His primary areas of study are Breast cancer, Internal medicine, Cancer, Oncology and Germline mutation. His Breast cancer study incorporates themes from Ovarian cancer and Single-nucleotide polymorphism, Genotype. Christoph Engel combines topics linked to Gastroenterology with his work on Internal medicine.
The Cancer study combines topics in areas such as Cancer research, Gynecology and Pathology. The concepts of his Oncology study are interwoven with issues in Prospective cohort study, Cohort study and Gene mutation. His biological study deals with issues like Kidney disease, which deal with fields such as Sepsis and Septic shock.
His scientific interests lie mostly in Internal medicine, Breast cancer, Oncology, Cancer and Ovarian cancer. Christoph Engel works mostly in the field of Internal medicine, limiting it down to topics relating to Germline mutation and, in certain cases, MSH2, as a part of the same area of interest. Breast cancer is the subject of his research, which falls under Genetics.
His study on Oncology also encompasses disciplines like
Christoph Engel mainly investigates Internal medicine, Oncology, Breast cancer, Cancer and Lynch syndrome. His Internal medicine research is multidisciplinary, incorporating perspectives in Single-nucleotide polymorphism and PALB2. His research in Oncology intersects with topics in CHEK2, Germline mutation, Gene, Germline and Genetic counseling.
His Breast cancer research incorporates themes from Cohort study, Retrospective cohort study, Mutation, Obstetrics and Prospective cohort study. Christoph Engel has researched Cancer in several fields, including Intensive care medicine, Disease, Biomarker, Thrombosis and D-dimer. His work carried out in the field of Lynch syndrome brings together such families of science as Endometrial cancer and MSH6.
Christoph Engel mostly deals with Internal medicine, Cancer, Oncology, Breast cancer and Lynch syndrome. Internal medicine is represented through his Ovarian cancer and Family history research. His work in the fields of Ovarian cancer, such as Brca1 2 mutation, overlaps with other areas such as Contralateral breast cancer.
His work in Oncology tackles topics such as Genetic counseling which are related to areas like Genetic testing, Hormone replacement therapy and Age dependent. The various areas that Christoph Engel examines in his Breast cancer study include Odds ratio, Prospective cohort study and PALB2. His research investigates the link between Lynch syndrome and topics such as Endometrial cancer that cross with problems in Hysterectomy, Gynecological surgery and Medical prescription.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
Frank M. Brunkhorst;Christoph Engel;Frank Bloos;Andreas Meier-Hellmann.
The New England Journal of Medicine (2008)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips.
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
Christoph Engel;Frank M. Brunkhorst;Hans-Georg Bone;Reinhard Brunkhorst.
Intensive Care Medicine (2007)
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
Alfons Meindl;Heide Hellebrand;Constanze Wiek;Verena Erven.
Nature Genetics (2010)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Guidelines for the clinical management of familial adenomatous polyposis (FAP)
H F A Vasen;G Möslein;A Alonso;S Aretz.
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
Hans F.A. Vasen;Gabriele Möslein;Angel Alonso;Inge Bernstein.
Journal of Medical Genetics (2007)
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Hans F A Vasen;Ignacio Blanco;Katja Aktan-Collan;Jessica P Gopie.
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: